exploring the frontiers of bioscience
The Paul G. Allen Frontiers Group takes our Founder’s enduring quest to understand the mysteries of bioscience to a global scale—beyond the science happening within the labs of the Allen Institute—by directing funding to researchers conducting cutting-edge science around the world. Our team is in continuous dialogue with scientists and visionaries in all areas of bioscience, constantly seeking the novel ideas and emerging fields where an early investment could have the power to make a difference for humankind.
The Frontiers Group encourages new ways of doing science, nurtures breakthroughs, and fosters a creative community built on a shared passion for discovery.
We seek the people and approaches at the edges of scientific exploration. We convene scientists and visionaries to identify the fields on the cusp of breakthroughs and generate ideas that will spur new directions in bioscience.
Funding new ideas
To accelerate discoveries, we encourage new approaches to address established scientific questions. We invest in investigators and centers who are gamechangers in their respective fields – innovators who are breaking down walls with the newest technologies and methodologies.
At Frontiers Group events, we bring together our community of creative thinkers and seekers, sparking conversations and collaborations that span disciplines. Our awardees become part of a network of like-minded pioneers who support and challenge each other in their efforts to tackle the biggest questions in bioscience.
News from The Paul G. Allen Frontiers Group
Simulations of life — in health and disease
August 1, 2019
Computational models that shed light on how we age, how cancer drugs work (or don’t work), how bacteria evade antibiotics and more highlighted in Exploring Frontiers symposium
These neurons are tied to one of multiple sclerosis’ most dramatic effects: Brain shrinkage
July 17, 2019
A new study identifies a type of brain cell that withers away in late stages of the disease
Advancing Leading Edge Cancer Research in a $4.5 Million Collaboration
July 11, 2019
LLS, The Mark Foundation for Cancer Research and The Paul G. Allen Frontiers Group Join Forces to Advance Leading Edge Cancer Research